Pro-Osteogenic Properties of Violina pumpkin (Cucurbita moschata) Leaf Extracts: Data from In Vitro Human Primary Cell Cultures.
Elisabetta LambertiniLetizia PenolazziGiulia PellieloCaterina PipinoAssunta PandolfiSerena FioritoFrancesco EpifanoSalvatore GenoveseRoberta PivaPublished in: Nutrients (2021)
Traditional medicines rely mainly on use of plant extracts to mitigate or treat a wide range of disorders, including those that affect skeletal homeostasis. In this study, we investigated for the first time the potential pro-osteogenic effects of hexane, acetone and methanol extracts of the leaves of Cucurbita moschata, a very popular pumpkin cultivar in Western countries. We found that in Cucurbita moschata leaves, there are acetone-extractable substances-in particular, fatty acids such as 13-OH-9Z,11E,15E-octadecatrienoic acid (PU-13OH-FA), which is capable of both stimulating the function of human primary osteoblasts, which are responsible for bone formation, and inhibiting the differentiation of human osteoclasts, which are responsible for bone resorption. This dual effect was monitored by analyzing Runx2 expression, deposition of mineralized matrix, ALP activity, TRAP and actin ring staining respectively. This study suggests that bioactive chemicals from Cucurbita moschata leaves are potentially suitable as therapeutics for managing metabolic bone disorders such as osteoporosis and rheumatoid arthritis, and promoting tissue healing and functional recovery after bone fractures. The data we obtained increase knowledge on the biological activities of Cucurbita moschata, and in particular underline the potential benefits of consuming leaves which are a part of the plant currently little considered in the Western world.
Keyphrases
- endothelial cells
- bone mineral density
- rheumatoid arthritis
- mesenchymal stem cells
- bone loss
- induced pluripotent stem cells
- pluripotent stem cells
- bone marrow
- postmenopausal women
- healthcare
- poor prognosis
- south africa
- soft tissue
- stem cells
- small molecule
- electronic health record
- cell therapy
- systemic lupus erythematosus
- human health
- high resolution
- drinking water
- body composition
- big data
- carbon dioxide
- data analysis
- binding protein
- idiopathic pulmonary fibrosis
- risk assessment